Sanjay Subramanian - Mar 11, 2025 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 11, 2025
Transactions value $
$0
Form type
4
Date filed
3/17/2025, 04:26 PM
Previous filing
Mar 15, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +145K $0.00 145K Mar 11, 2025 Common Stock 145K $1.06 Direct F1, F2
transaction INZY Restricted Stock Units Award $0 +38.5K $0.00 38.5K Mar 11, 2025 Common Stock 38.5K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price represents the closing price of the Issuer's common stock on March 11, 2025.
F2 The option was granted on March 11, 2025 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.
F3 The restricted stock units were granted on March 11, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. 33% of the restricted stock units vest on March 11, 2026, with the remaining 67% vesting in eight equal quarterly installments thereafter, such that the restricted stock units will be fully vested on March 11, 2028.